Literature DB >> 7673213

Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol.

K Hattori1, M Hattori, H Adachi, M Tsujimoto, H Arai, K Inoue.   

Abstract

Platelet-activating factor (PAF) acetylhydrolase, which inactivates PAF by removing the acetyl group at the sn-2 position, is distributed widely in plasma and tissues. In a previous study, we demonstrated that the PAF acetylhydrolase activity present in the soluble fraction of bovine brain cortex could be separated chromatographically into three peaks (tentatively designated isoforms Ia, Ib, and II) (Hattori, M., Arai, H., and Inoue, K. (1993) J. Biol. Chem. 268, 18748-18753). In this study, these three isoforms were also detected in kidney and liver cytosols, although their relative activity ratios in these tissues differed. In particular, isoform II was responsible for the majority of the bovine liver PAF acetylhydrolase activity. We purified isoform II from bovine liver cytosol to near homogeneity and demonstrated that it is a single 40-kDa polypeptide. This enzyme was inactivated by diisopropyl fluorophosphate and 5,5'-dithiobis(2-nitrobenzoic acid), suggesting that both serine and cysteine residues are required for the enzyme activity, and [3H]diisopropyl fluorophosphate labeled only the 40-kDa polypeptide, confirming the enzyme's identity. Isoform II showed a comparatively broader substrate specificity than isoform Ib. Isoform II hydrolyzed propionyl and butyroyl moieties at the sn-2 position approximately half as effectively as it did PAF, whereas isoform Ib hardly hydrolyzed these substrates. Taken together with previous data, the current findings indicate that tissue cytosol contains at least two types of PAF acetylhydrolase with respect to polypeptide composition, substrate specificity, and tissue distribution and suggest that these two enzymes may share distinct physiological functions in tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673213     DOI: 10.1074/jbc.270.38.22308

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.

Authors:  Melinda M Mulvihill; Daniel I Benjamin; Xiaodan Ji; Erwan Le Scolan; Sharon M Louie; Alice Shieh; McKenna Green; Tara Narasimhalu; Patrick J Morris; Kunxin Luo; Daniel K Nomura
Journal:  Chem Biol       Date:  2014-06-19

Review 2.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

3.  Trafficking of platelet-activating factor acetylhydrolase type II in response to oxidative stress.

Authors:  Anastasia F Thévenin; Elizabeth S Monillas; Jason M Winget; Kirk Czymmek; Brian J Bahnson
Journal:  Biochemistry       Date:  2011-09-12       Impact factor: 3.162

4.  Oxidatively truncated phospholipids are required agents of tumor necrosis factor α (TNFα)-induced apoptosis.

Authors:  Calivarathan Latchoumycandane; Gopal K Marathe; Renliang Zhang; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

5.  Phospholipase A2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase.

Authors:  S Soubeyrand; C Lazure; P Manjunath
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

6.  Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.

Authors:  S Q Rice; C Southan; H F Boyd; J A Terrett; C H MacPhee; K Moores; I S Gloger; D G Tew
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

7.  Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.

Authors:  D M Stafforini; K Satoh; D L Atkinson; L W Tjoelker; C Eberhardt; H Yoshida; T Imaizumi; S Takamatsu; G A Zimmerman; T M McIntyre; P W Gray; S M Prescott
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

8.  Type II platelet-activating factor-acetylhydrolase is essential for epithelial morphogenesis in Caenorhabditis elegans.

Authors:  Takao Inoue; Asako Sugimoto; Yuka Suzuki; Masayuki Yamamoto; Masafumi Tsujimoto; Keizo Inoue; Junken Aoki; Hiroyuki Arai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

9.  Aldose reductase-catalyzed reduction of aldehyde phospholipids.

Authors:  Sanjay Srivastava; Matthew Spite; John O Trent; Matthew B West; Yonis Ahmed; Aruni Bhatnagar
Journal:  J Biol Chem       Date:  2004-10-01       Impact factor: 5.157

10.  A yeast PAF acetylhydrolase ortholog suppresses oxidative death.

Authors:  Jason M Foulks; Andrew S Weyrich; Guy A Zimmerman; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2008-05-03       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.